Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies

Qing-Ge Zhu; Shi-Ming Zhang; Xiao-Xiao Ding; Bing He; Hu-Qin Zhang

doi:10.18632/oncotarget.17016

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies

Qing-Ge Zhu, Shi-Ming Zhang, Xiao-Xiao Ding, Bing He and Hu-Qin Zhang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:57680-57692. https://doi.org/10.18632/oncotarget.17016

Metrics: PDF 3785 views | HTML 4430 views | ?

Abstract

Qing-Ge Zhu1,*, Shi-Ming Zhang1,*, Xiao-Xiao Ding1,*, Bing He1 and Hu-Qin Zhang1

1The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an Jiaotong University, Xi’an 710049, P.R. China

*These authors contributed equally to the work

Correspondence to:

Hu-Qin Zhang, email: [email protected]

Bing He, email: [email protected]

Keywords: driver genes, non-small cell lung cancer, characteristics, detection methods, targeted therapies

Received: February 23, 2017 Accepted: March 30, 2017 Published: April 10, 2017

ABSTRACT

Lung cancer is one of the most common causes of cancer-related death in the world. The large number of lung cancer cases is non-small cell lung cancer (NSCLC), which approximately accounting for 75% of lung cancer. Over the past years, our comprehensive knowledge about the molecular biology of NSCLC has been rapidly enriching, which has promoted the discovery of driver genes in NSCLC and directed FDA-approved targeted therapies. Of course, the targeted therapies based on driver genes provide a more exact option for advanced non-small cell lung cancer, improving the survival rate of patients. Now, we will review the landscape of driver genes in NSCLC including the characteristics, detection methods, the application of target therapy and challenges.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17016

Publication Alerts

Reviews:

Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies

Abstract